Awarded
Treosulfan 5 g in 100 ml Fertiglsg. Pulver zur Herstellung einer Infusionslösung (Indikation: Ovarialkarzinome) St
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- PBMG eG
- Winners
- Zentiva Pharma GmbH
- Contract value
- no value published
- Bids received
- 2
- Published
- 16 Oct 2026
- Awarded
- 16 Oct 2026
- Contract start
- 1 Jul 2027
- Contract end
- 30 Jun 2029stated
- Region
- Hamburg
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Propofol 200 mg in 20 ml Lsg. Emulsion Durchstechflaschen St a 20 ml | PBMG eG | Baxter Deutschland GmbH | — | 20 Oct 2026 |
| Lidocain 1% Injektionslösung St a 50 ml | PBMG eG | DELTAMEDICA GmbH | — | 20 Oct 2026 |
| Lidocain 1% Injektionslösung St a 10 ml | PBMG eG | DELTAMEDICA GmbH | — | 20 Oct 2026 |
| Oxycodon hydrochlorid 5 mg Retard-Tabletten St | PBMG eG | HEXAL AG | — | 20 Oct 2026 |
| Oxycodon hydrochlorid 40 mg Retard-Tabletten St | PBMG eG | HEXAL AG | — | 20 Oct 2026 |
| Oxycodon hydrochlorid 20 mg Retard-Tabletten St | PBMG eG | HEXAL AG | — | 20 Oct 2026 |